MedX Health Corp
MDX.V
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 28.70% | 1.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 28.70% | 1.12% | |||
| Cost of Revenue | -60.83% | 197.61% | |||
| Gross Profit | 139.79% | -517.04% | |||
| SG&A Expenses | -14.80% | 22.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.96% | 36.77% | |||
| Operating Income | 27.51% | -42.27% | |||
| Income Before Tax | 41.02% | -60.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.02% | -60.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.02% | -60.03% | |||
| EBIT | 27.51% | -42.27% | |||
| EBITDA | 63.05% | -183.04% | |||
| EPS Basic | 42.55% | -51.61% | |||
| Normalized Basic EPS | 34.62% | -36.84% | |||
| EPS Diluted | 42.55% | -51.61% | |||
| Normalized Diluted EPS | 34.62% | -36.84% | |||
| Average Basic Shares Outstanding | 2.43% | 6.08% | |||
| Average Diluted Shares Outstanding | 2.43% | 6.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||